ABVC BioPharma (ABVC) Earnings Date & Reports

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABVC is expected to report earnings to rise 900.00% to -60 cents per share on August 15

ABVC BioPharma ABVC Stock Earnings Reports

Q2'23

Est.

$-0.60

Q1'23

Missed

by $0.01

Q4'22

Est.

$-0.15

Q3'22

Beat

by $0.09

Q2'22

Beat

by $0.06

The last earnings report on May 15 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 100.63K shares outstanding, the current market capitalization sits at 15.13M.

View a ticker or compare two or three

Compare

ABVC